Product correctly added to cart.

Standards and Solutions in Compliance with Pharmacopoeias
Standards and Solutions in Compliance with Pharmacopoeias

Standards and Solutions in Compliance with Pharmacopoeias

Standards and solutions in compliance with pharmacopoeias are essential reference materials used to ensure the quality, safety, and efficacy of pharmaceutical products. This category includes a wide range of solutions and reagents that adhere to the stringent requirements set forth by various pharmacopoeias, such as the European Pharmacopoeia (EP) and the British Pharmacopoeia (BP). These standards are critical for the calibration and validation of analytical methods, ensuring that pharmaceutical products meet regulatory standards. They support a broad spectrum of applications, including the analysis of active pharmaceutical ingredients (APIs), excipients, and finished drug products. By providing consistent and reliable reference points, these standards and solutions facilitate compliance with regulatory requirements, enhance quality control processes, and ensure the production of safe and effective pharmaceuticals. Their use is indispensable in pharmaceutical research, development, and manufacturing, ensuring that products adhere to the highest quality standards.

Read more

Products of "Standards and Solutions in Compliance with Pharmacopoeias"

Sort by


See more categories

This search does not contain any category.

products per page. 4391 products on this category.

BrandProduct dataPurityPrice rangeEstimated delivery
British Pharmacopoeia logo
Hyoscine hydrobromide
REF: 47-199
CAS: 6533-68-2
88.3%235.00 €Mon 04 Nov 24
EDQM - European Pharmacopoeia logo
Buserelin CRS
REF: 41-B1168000
CAS: 68630-75-1
- - -115.00 €Mon 04 Nov 24
EDQM - European Pharmacopoeia logo
Tamsulosin hydrochloride CRS
REF: 41-Y0000650
CAS: 106463-17-6
- - -115.00 €Mon 04 Nov 24
EDQM - European Pharmacopoeia logo
Dipyridamole CRS
REF: 41-D2850000
CAS: 58-32-2
- - -115.00 €Mon 04 Nov 24
EDQM - European Pharmacopoeia logo
Tianeptine impurity A CRS
REF: 41-Y0000153
CAS: 29823-18-5
- - -115.00 €Mon 04 Nov 24
EDQM - European Pharmacopoeia logo
Tapentadol impurity A CRS
REF: 41-Y0002113
CAS: 953400-57-2
- - -115.00 €Mon 04 Nov 24
British Pharmacopoeia logo
Amitraz
REF: 47-15
CAS: 33089-61-1
99.5%235.00 €Mon 04 Nov 24
EDQM - European Pharmacopoeia logo
Phenylmercuric borate - reference spectrum
REF: 41-P1255100
- - -115.00 €Mon 04 Nov 24
EDQM - European Pharmacopoeia logo
Vinpocetine CRS
REF: 41-Y0000589
CAS: 42971-09-5
- - -115.00 €Mon 04 Nov 24
British Pharmacopoeia logo
Methyldopa
REF: 47-240
CAS: 555-30-6
88.6%235.00 €Mon 04 Nov 24
EDQM - European Pharmacopoeia logo
Domperidone CRS
REF: 41-D2955000
CAS: 57808-66-9
- - -115.00 €Mon 04 Nov 24
EDQM - European Pharmacopoeia logo
Megestrol acetate for system suitability CRS
REF: 41-Y0001524
CAS: 595-33-5
- - -115.00 €Mon 04 Nov 24
EDQM - European Pharmacopoeia logo
Testosterone caproate CRS
REF: 41-T0210000
- - -115.00 €Mon 04 Nov 24
EDQM - European Pharmacopoeia logo
Fluvoxamine impurity D CRS
REF: 41-Y0000916
- - -115.00 €Mon 04 Nov 24
EDQM - European Pharmacopoeia logo
Hydrochlorothiazide CRS
REF: 41-H1200000
CAS: 58-93-5
- - -115.00 €Mon 04 Nov 24
British Pharmacopoeia logo
Alfuzosin impurity standard
REF: 47-847
CAS:
- - -205.00 €Mon 04 Nov 24
EDQM - European Pharmacopoeia logo
Mirabegron impurity B CRS
REF: 41-Y0002373
CAS: 521284-22-0
- - -115.00 €Mon 04 Nov 24
British Pharmacopoeia logo
Doxepin impurity standard
REF: 47-823
CAS:
- - -205.00 €Mon 04 Nov 24
EDQM - European Pharmacopoeia logo
Carboplatin - reference spectrum
REF: 41-C0550000
- - -115.00 €Mon 04 Nov 24
EDQM - European Pharmacopoeia logo
Latanoprost for system suitability CRS
REF: 41-Y0002189
- - -1,516.00 €Mon 04 Nov 24
discount label

Hyoscine hydrobromide


Ref: 47-199

200mg235.00 €
Estimated delivery in United States, on Monday 4 Nov 2024
discount label

Ref: 41-B1168000

12.18mg115.00 €
Estimated delivery in United States, on Monday 4 Nov 2024
discount label

Tamsulosin hydrochloride CRS


Ref: 41-Y0000650

10mg115.00 €
Estimated delivery in United States, on Monday 4 Nov 2024
discount label

Dipyridamole CRS


Ref: 41-D2850000

50mg115.00 €
Estimated delivery in United States, on Monday 4 Nov 2024
discount label

Ref: 41-Y0000153

80mg115.00 €
Estimated delivery in United States, on Monday 4 Nov 2024
discount label

Ref: 41-Y0002113

10mg115.00 €
Estimated delivery in United States, on Monday 4 Nov 2024
discount label

Amitraz


Ref: 47-15

200mg235.00 €
Estimated delivery in United States, on Monday 4 Nov 2024
discount label

Ref: 41-P1255100

1u115.00 €
Estimated delivery in United States, on Monday 4 Nov 2024
discount label

Vinpocetine CRS


Ref: 41-Y0000589

10mg115.00 €
Estimated delivery in United States, on Monday 4 Nov 2024
discount label

Methyldopa


Ref: 47-240

100mg235.00 €
Estimated delivery in United States, on Monday 4 Nov 2024
discount label

Domperidone CRS


Ref: 41-D2955000

120mg115.00 €
Estimated delivery in United States, on Monday 4 Nov 2024
discount label

Megestrol acetate for system suitability CRS


Ref: 41-Y0001524

50mg115.00 €
Estimated delivery in United States, on Monday 4 Nov 2024
discount label

Ref: 41-T0210000

20mg115.00 €
Estimated delivery in United States, on Monday 4 Nov 2024
discount label

Ref: 41-Y0000916

10mg115.00 €
Estimated delivery in United States, on Monday 4 Nov 2024
discount label

Hydrochlorothiazide CRS


Ref: 41-H1200000

300mg115.00 €
Estimated delivery in United States, on Monday 4 Nov 2024
discount label

Ref: 47-847

25mg205.00 €
Estimated delivery in United States, on Monday 4 Nov 2024
discount label

Ref: 41-Y0002373

10mg115.00 €
Estimated delivery in United States, on Monday 4 Nov 2024
discount label

Ref: 47-823

25mg205.00 €
Estimated delivery in United States, on Monday 4 Nov 2024
discount label

Ref: 41-C0550000

1u115.00 €
Estimated delivery in United States, on Monday 4 Nov 2024
discount label

Ref: 41-Y0002189

2mg1,516.00 €
Estimated delivery in United States, on Monday 4 Nov 2024
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".